Irx Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2020.
2020 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Irx Pharmaceuticals Private Limited

Irx Pharmaceuticals Private Limited, a active private limited company, was established on 14 October 2020 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110DL2020PTC371543. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹98.06 K .

Its leadership includes Mahipal Singh Sachdev (Director), Ajay Jassal (Director), Shankar Narang (Director). Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-5/24 Safdarjung Enclave, New Delhi, Delhi, 110029.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110DL2020PTC371543

  • Registration Number

    371543

  • Incorporation Date

    14 October 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹98.06 K

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 98.06 K
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 93.38%
  • Profit Growth **** 90.17%
  • Ebitda **** 87.45%
  • Net Worth 195.24%
  • Total Assets **** 176.04%
Company report

Irx Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Irx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Irx Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahipal Singh Sachdev Director 14 Oct 2020 Current
Ajay Jassal Director 28 Feb 2025 Current
Shankar Narang Director 28 Feb 2025 Current
Alka Sachdev Director 28 Feb 2025 Current
Ritika Sachdev Gupta Director 14 Oct 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Irx Pharmaceuticals.

Irx Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 93.38% increase. The company also saw a substantial improvement in profitability, with a 90.17% increase in profit. The company's net worth Soared by an impressive increase of 195.24%.

Irx Pharmaceuticals revenue growth over time
Irx Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 93.38%
*******
*******
*******
*******
Revenue from Operations
*******
 91.58%
*******
*******
*******
*******
Total Assets
*******
 176.04%
*******
*******
*******
*******
Profit or Loss
*******
 90.17%
*******
*******
*******
*******
Net Worth
*******
 195.24%
*******
*******
*******
*******
EBITDA
*******
 87.45%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Irx Pharmaceuticals?

In 2023, Irx Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Irx Pharmaceuticals?

Irx Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Irx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Irx Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Irx Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Irx Pharmaceuticals Private Limited last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Irx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Ajay Jassal was appointed as a Director was appointed as a Director on 28 Feb 2025 & has been associated with this company since 11 months 18 days . was documented.

  • Director Appointment

    Shankar Narang was appointed as a Director was appointed as a Director on 28 Feb 2025 & has been associated with this company since 11 months 18 days . was recorded as a recent event.

  • Director Appointment

    Progress on Alka Sachdev was appointed as a Director was appointed as a Director on 28 Feb 2025 & has been associated with this company since 11 months 18 days . was documented.

  • Director Appointment

    Progress on Mahipal Singh Sachdev was appointed as a Director was appointed as a Director on 14 Oct 2020 & has been associated with this company since 5 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Irx Pharmaceuticals Private Limited?

The CIN of Irx Pharmaceuticals Private Limited is U24110DL2020PTC371543.

Where is Irx Pharmaceuticals Private Limited headquartered?

Irx Pharmaceuticals Private Limited is headquartered at B-5/24 Safdarjung Enclave, New Delhi, Delhi, 110029.

When was Irx Pharmaceuticals Private Limited incorporated?

Irx Pharmaceuticals Private Limited was incorporated on 14 October 2020.

Who are the current directors of Irx Pharmaceuticals Private Limited?

The current directors of Irx Pharmaceuticals Private Limited are

What is the primary industry of Irx Pharmaceuticals Private Limited?

The primary industry of Irx Pharmaceuticals Private Limited is Trade.

Is Irx Pharmaceuticals Private Limited a listed company?

Irx Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Irx Pharmaceuticals Private Limited?

The authorized capital of Irx Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹98.06 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available